9-O-Demethylmitragynine (9-ODM): chemistry
Structure
PubChem records the compound as “9-O-Demethylmitragynine”, CAS number “425623-55-8”, with “9-Hydroxycorynantheidine” as a synonym.[1] Its formula is “C22H28N2O4” and its molecular weight “384.5 g/mol”.[1] Mitragynine, the main kratom alkaloid, is “C23H30N2O4” at “398.5 g/mol”.[2] The difference is one carbon and two hydrogens: a methyl group.
The two systematic names show where it comes off. Mitragynine's is “methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate”.[2] 9-ODM's is “methyl (E)-2-[(2S,3S,12bS)-3-ethyl-8-hydroxy-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl]-3-methoxyprop-2-enoate”.[1][2] The names are identical except for one word, methoxy against hydroxy: the methoxy group on the indole ring becomes a hydroxyl, and the stereochemistry is the same.[1][2]
Two numbering systems, three names
Alkaloid chemists number that ring position 9, which gives the names 9-O-demethylmitragynine and 9-hydroxycorynantheidine.[1] The systematic name numbers the same position 8 (“8-hydroxy”).[1] Florida's emergency rule of July 2026 listed the compound as “9-Hydroxycorynantheidine (9-O-Demethylmitragynine, 8-OH)”, using both.[3] All of these name one compound. Pack names such as MIT-9 and C9 are not chemical names and do not identify a compound; the general section explains why.
How it is made
It can be made from mitragynine in the laboratory: the 2006 study that first tested it on opioid receptors noted that it “is synthesized from mitragynine”.[4] No published source was found describing how the compound in commercial tablets is made.
The body makes it too. Testing individual human liver enzymes, a 2020 study reported that “9-O-demethylmitragynine, the most abundant metabolite in vitro (and the most prevalent metabolite in urine among kratom users) was produced by 2C19, 3A4 and 2D6”.[5] By comparison, 7-hydroxymitragynine “was produced exclusively by 3A4”.[5] A 2024 study with human liver fractions found that “9-O-demethylmitragynine is a major metabolite formed from mitragynine metabolism (36 % total metabolism) and displays similar pharmacologic activity”.[6] In rats given mitragynine by mouth, “the major metabolites were mitragynine acid and 9-hydroxycorynantheidine”.[7]
In blood and urine
In urine from cases involving kratom, “9-O-Demethylmitragynine and 7-hydroxymitragynine were identified in unhydrolyzed urine in 75% and 63% of the cases”.[8] In plasma from regular kratom users, a 2026 method paper found “mitragynine 16-carboxylic acid and 9-hydroxycorynantheidine being the major circulating metabolites of mitragynine in plasma upon kratom oral administration”.[9] A practical consequence: a positive urine or blood test for 9-ODM does not show that someone took a 9-ODM product, because kratom itself produces it.[5][9]
Stability
The same paper had to treat it as fragile: “Chemically unstable metabolites, 7-hydroxymitragynine and 9-hydroxycorynantheidine, were stabilized in human plasma”.[9] That finding is about blood samples. How the compound keeps in a tablet on a shelf has not been published.[9]
References
- 9-O-Demethylmitragynine, PubChem compound record CID 10927114 — National Center for Biotechnology Information, PubChem
- Mitragynine, PubChem compound record CID 3034396 — National Center for Biotechnology Information, PubChem
- Rule 2ER26-1 (emergency rule), Florida Department of Legal Affairs (Wayback Machine copy of the rule page) — Florida Department of State, Florida Administrative Code
- Partial agonistic effect of 9-hydroxycorynantheidine on mu-opioid receptor in the guinea-pig ileum (Matsumoto et al., Life Sciences 2006) — PubMed (US National Library of Medicine)
- CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine (Basiliere and Kerrigan, Journal of Analytical Toxicology 2020) — PubMed (US National Library of Medicine)
- An in vitro evaluation on metabolism of mitragynine to 9-O-demethylmitragynine (Melchert, Zhang and Markowitz, Chemico-Biological Interactions 2024) — PubMed (US National Library of Medicine)
- Multiple-Dose Pharmacokinetics and Safety of Mitragynine, the Major Alkaloid of Kratom, in Rats (Chiang et al., ACS Pharmacology and Translational Science 2024) — PubMed (US National Library of Medicine)
- Identification of metabolites and potential biomarkers of kratom in urine (Basiliere and Kerrigan, Journal of Chromatography B 2020) — PubMed (US National Library of Medicine)
- Simultaneous quantification of seventeen kratom alkaloids and metabolites in human plasma and its application to clinical pharmacokinetic sample analysis (Kanumuri et al., Pharmaceutical Biology 2026) — PubMed (US National Library of Medicine)
Comments
Sign in to join the conversation.
No comments yet.